- Recent Funding
- Investors
- Baird Capital
Baird Capital portfolio
Baird Capital has 3 portfolio companies on record at Recent Funding.
About this page
It is a venture capital firm based in Chicago, US, founded in 1989. It led 2 of the 5 rounds it joined. Its most recent investment on record is Strata Oncology's $90M Series B+ round in July 2021, alongside Merck Global Health Innovation Fund, Monashee Investment Management, Wellington Management and 6 others. By category, its portfolio leans toward Health and bio (1) and Cybersecurity (1). It has co-invested with Merck Global Health Innovation Fund, Deerfield and Pfizer Venture Investments, most often Merck Global Health Innovation Fund (2 rounds).
About Baird Capital
What Baird Capital invests in
- Health and bio · 1 · 33%
- Cybersecurity · 1 · 33%
- Developer tools and cloud · 1 · 33%
- Sales and marketing · 1 · 33%
- Data and analytics · 1 · 33%
- Media and content · 1 · 33%
Baird Capital recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| Series B+ · $90M | Merck Global Health Innovation Fund, Monashee Investment Management, Wellington Management (lead) +6 | ||
| Series B+ · $15M | MATH Venture Partners, Jump Capital, Forgepoint Capital (lead) | ||
| Series B+ · $26M | Merck Global Health Innovation Fund, Renaissance Venture Capital, Pfizer Venture Investments (lead) +2 | ||
| Series A · $12M · lead | eLab Ventures, Arboretum Ventures (lead) | ||
| Series A · $13M · lead | MATH Venture Partners, Jump Capital |
How Baird Capital invests
Baird Capital portfolio companies
SStrata Oncology$90MSeries B+ · Jul 2021
NNowSecure$15MSeries B+ · Jun 2019
FFullcontactbacker
| Company | Round with Baird Capital | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $90M | $128M | Jul 28, 2021 Series B+ |
Cybersecurity |
Series B+ · $15M | $28M | Sep 28, 2024 Series B+ |
Sales and marketing |
backer | undisclosed | — |
Most frequent co-investors
MMerck Global Health Innovation Fund2 shared rounds · last Jul 28, 2021
DDeerfield2 shared rounds · last Jul 28, 2021
PPfizer Venture Investments2 shared rounds · last Jul 28, 2021
RRenaissance Venture Capital2 shared rounds · last Jul 28, 2021JJump Capital2 shared rounds · last Jun 1, 2019
MMATH Venture Partners2 shared rounds · last Jun 1, 2019
AArboretum Ventures2 shared rounds · last May 1, 2018
WWellington Management1 shared round · last Jul 28, 2021
MMonashee Investment Management1 shared round · last Jul 28, 2021
CCormorant Asset Management1 shared round · last Jul 28, 2021
- HHighside Capital Management1 shared round · last Jul 28, 2021
HHighline Capital Management1 shared round · last Jul 28, 2021
Similar investors
LLitquidity Ventures5 companies · 4 deals in 12 mo
SSAIC5 companies · 4 deals in 12 mo
IIthaca Investments5 companies · 3 deals in 12 mo
AArthur Ventures6 companies · 3 deals in 12 mo
SSwish Ventures6 companies · 3 deals in 12 mo
MMerlin Ventures6 companies · 1 deal in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.
Share is of the 5 rounds on Recent Funding that name Baird Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Baird Capital, which is a subset of its real portfolio. API: /api/v1/investors/baird-capital (get a free API key). More: the most active VC firms and new venture capital funds.